ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.150
-0.050 (-1.56%)
Sep 18, 2026, 4:08 PM HKT
| Market Cap | 1.35B -71.2% |
| Revenue (ttm) | 170.32M +20.1% |
| Net Income | -265.74M |
| EPS | -0.63 |
| Shares Out | 429.66M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 227,200 |
| Open | 3.375 |
| Previous Close | 3.200 |
| Day's Range | 3.150 - 3.375 |
| 52-Week Range | 2.800 - 16.800 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |